资讯

来自MSN1月
Japan’s MHLW approves Sarepta’s gene therapy for DMD - MSN
The Japanese Ministry of Health, Labour, and Welfare (MHLW) has granted approval to Sarepta Therapeutics’ gene therapy Elevidys (delandistrogene moxeparvovec) for treating Duchenne muscular ...
Investing2月
Japan approves Sarepta’s DMD gene therapy for young children
The company reported lower-than-expected revenue for its gene therapy product, Elevidys, in the first quarter of 2025, which amounted to $375 million, falling short of the $444 million forecasted ...
Nature6 年
Japan responds: stem-cell therapy justified - Nature
As director-general of the Pharmaceutical Safety and Environmental Health Bureau of Japan’s Ministry of Health, Labour and Welfare, I cannot accept your criticism of our approval of stem-cell ...
Navy Pilots with ALS Fight for Access to the Stem Cell Therapy That Can Help Them Live
Matt Bellina Regained Function After Receiving NurOwn via the Right to Try Law He Fought to Pass and Now He is Fighting for All Americans with ALS to Get the Same Chance He Did BREMERTON, WA / ACCESS ...
Nippon3 年
Medical Access for All: A Taiwanese Doctor’s Work to Bring Care to ...
After earning his MD from Kaohsiung Medical University in 2013, he went to work as a doctor in Taiwan. Having been born in Japan, though, where he lived up through age five, his ties with the ...